Actionable news
0
All posts from Actionable news
Actionable news in HRTX: HERON THERAPEUTICS INC,

How one investor is playing Heron

A large trade is apparently anticipating good news on two fronts from Heron Therapeutics by early next year.

The biotechnology company announced in its earnings report this month that it began commercial sales of its Sustol drug in October, an extended-release injection to treat nausea associated with chemotherapy. In addition, Heron said it will update results from Phase II clinical trials of its HTX-011 post-surgery pain medication in early 2017.

The timing of these announcements could well be the reason that our systems...


More